SecBot SecBot

XNCR

Xencor Inc
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001326732 Biotech & Drug Discovery
$35.40 −1.69 (−4.56%)
Nov 16 4:00 PM ET · prev $37.09
Market cap
$2.9B
Mid cap
Consensus
Buy
85% Buy or better · 20 analysts
Median target
$43.50
+23% · range $21.00–70.00
1 year
+126.6%
from $15.62 · Nov 17
30 days
+52.7%
from $23.19
52-week range
$10.41–39.97
−11% from high · low May 19
Avg volume 20D
1.76M
Oct 26 spike 8.90M
Short interest
12.90M
≈17.2% of shares · +5.1%
Days to cover
6.6
at average volume
Insider net
−$4.4M
0 buyers · 9 sellers · 12 mo
New fund stakes
1
Q3 2026 13F · 0 exits
Filing reports
20
analyzed by SecBot
SecBot read MIXED 10 reports · 90 days
Balance 1 bearish · 1 bullish · 8 neutral oldest → newest, height = score
Avg score ·High conf. 9/10

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    9 insiders sold $4.4M.

  • InstitutionsBULLISH

    Q3 2026: 21 added (1 new), 14 trimmed or exited.

  • AnalystsBULLISH

    17 of 20 rate it Buy or better. Median target $43.50 (+23%).

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.775 → −$0.846 over 90 days. 2 up, 3 down in 30 days.

  • Short sellersSTEADY

    Short interest +5.1% to 12.90M shares. 6.6 days to cover, ≈17.2% of shares.

  • TrendUPTREND

    29% above its 50-day average. New closing high $39.97 on Nov 11.

Who's buying

13F· Q3 2026
1
new positions
0
exits
FundMoveSharesValue
Jefferies Financial Group Inc.DOUBLED2,082,243$52.0M
Invesco Ltd.DOUBLED870,915$21.7M
UBS Group AGTRIM647,242$16.1M
PANAGORA ASSET MANAGEMENT INCTRIM439,332$11.0M
HRT FINANCIAL LPDOUBLED258,942$6.5M
RAYMOND JAMES FINANCIAL INCADD110,165$2.7M
Squarepoint Ops LLCDOUBLED106,287$2.7M
BNP PARIBAS FINANCIAL MARKETSADD102,759$2.6M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

20 analysts
Buy 85% rate it Buy or better
Strong Buy6Buy11Hold3Sell0Strong Sell0
12-month targets · 12 analysts

Price is inside the target range. Median implies +23%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 5, 2026Cantor Fitzgerald
REITERATE
REITERATEOverweight
Oct 27, 2026Truist Securities
MAINTAIN
MAINTAINBuy
Oct 27, 2026RBC Capital
MAINTAIN
MAINTAINOutperform
Oct 27, 2026Wells Fargo
MAINTAIN
MAINTAINOverweight
Oct 27, 2026Wedbush
MAINTAIN
MAINTAINOutperform
Oct 26, 2026Cantor Fitzgerald
MAINTAIN
MAINTAINOverweight

Insider ledger

Form 4
$0
bought · 0 insiders
$4.4M
sold · 9 insiders
DateInsiderTypeValue
Nov 11, 2026
Cornelissen Bart Jan
SR. VICE PRESIDENT & CFO
Nov 11, 2026
SELL$402.2K
Nov 10, 2026
RANIERI RICHARD J
Director
Nov 10, 2026
EXERCISE$345.6K
Nov 10, 2026
RANIERI RICHARD J
Director
Nov 10, 2026
EXERCISE$569.1K
Nov 10, 2026
RANIERI RICHARD J
Director
Nov 10, 2026
EXERCISE$255.1K
Nov 10, 2026
RANIERI RICHARD J
Director
Nov 10, 2026
EXERCISE$258.1K
Nov 10, 2026
RANIERI RICHARD J
Director
Nov 10, 2026
SELL$2.7M
Nov 10, 2026
RANIERI RICHARD J
Director
Nov 10, 2026
SELL$442.3K
Jun 18, 2026
Feigal Ellen
Director
Jun 18, 2026
SELL$89.4K

Earnings setup

Estimates
−$0.85
EPS estimate, this quarter
−9%
estimate change, 90 days
2↑ 3↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.85-$1.30–-$0.12-3.3%$31.3M
Next Q-$0.96-$1.31–-$0.70-5.1%$18.1M
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
12,896,418
shares short
+5.1%
vs prior settlement
6.6
days to cover
≈17.2%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 13, 2026 SEC
Toronto-Dominion Bank disclosed a new passive 5.2% stake in Xencor Inc as of September 30, 2026, holding 3,871,296…
SC 13G · Impact 3/10
Nov 12, 2026 SEC
Two Xencor insiders, including the CFO, sold a combined $3.15M in open-market stock during the week following Q3…
CLUSTER · Impact 4/10
Nov 11, 2026 Insider
Cornelissen Bart Jan sold 10,100 shares
SR. VICE PRESIDENT & CFO @ $39.82 ($402.2K)
Nov 10, 2026 Insider
RANIERI RICHARD J acquired via exercise 15,000 shares
Director @ $23.04 ($345.6K)
Nov 10, 2026 Insider
RANIERI RICHARD J acquired via exercise 21,412 shares
Director @ $26.58 ($569.1K)
Nov 9, 2026 Earnings calendar
XNCR Q3 2026 Earnings Scheduled · 2026-11-09
Sep 30, 2026 Inst.
Jefferies Financial Group Inc. · DOUBLED
2,082,243 shares ($52.0M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
2 drugs tracked · Drug pipeline →
Recent

SecBot reports

20 filings · 4 bullish · 3 bearish · 13 neutral
All XNCR filing & press-release reports (20)